MicroPort Scientific 将来の成長

Future 基準チェック /16

MicroPort Scientific利益と収益がそれぞれ年間72.7%と15.3%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に-19.8% 72%なると予測されています。

主要情報

72.7%

収益成長率

72.0%

EPS成長率

Medical Equipment 収益成長	14.3%
収益成長率	15.3%
将来の株主資本利益率	-19.8%
アナリストカバレッジ	Good
最終更新日	08 Nov 2024

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

DB:MSK - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	1,577	-17	165	56	5
12/31/2025	1,297	-158	108	-213	8
12/31/2024	1,111	-211	-173	-192	6
6/30/2024	1,027	-412	-269	-102	N/A
3/31/2024	989	-445	-350	-167	N/A
12/31/2023	951	-478	-431	-232	N/A
9/30/2023	935	-439	-513	-288	N/A
6/30/2023	918	-401	-595	-345	N/A
3/31/2023	880	-419	-598	-344	N/A
12/31/2022	841	-437	-601	-343	N/A
9/30/2022	820	-410	-603	-328	N/A
6/30/2022	799	-384	-605	-313	N/A
3/31/2022	789	-330	-555	-285	N/A
12/31/2021	779	-276	-505	-258	N/A
9/30/2021	753	-246	-382	-198	N/A
6/30/2021	726	-216	-260	-138	N/A
3/31/2021	688	-204	-202	-81	N/A
12/31/2020	649	-191	-144	-23	N/A
9/30/2020	678	-138	-119	0	N/A
6/30/2020	708	-85	-93	24	N/A
3/31/2020	751	-19	-91	25	N/A
12/31/2019	793	46	-89	26	N/A
9/30/2019	773	56	-79	35	N/A
6/30/2019	752	66	-70	44	N/A
3/31/2019	711	45	-38	64	N/A
12/31/2018	669	24	-6	84	N/A
9/30/2018	603	23	4	95	N/A
6/30/2018	537	21	13	106	N/A
3/31/2018	490	20	N/A	102	N/A
12/31/2017	444	19	N/A	97	N/A
9/30/2017	426	25	N/A	93	N/A
6/30/2017	409	31	N/A	89	N/A
3/31/2017	399	22	N/A	86	N/A
12/31/2016	390	14	N/A	83	N/A
9/30/2016	387	5	N/A	68	N/A
6/30/2016	383	-4	N/A	54	N/A
3/31/2016	379	-8	N/A	42	N/A
12/31/2015	376	-12	N/A	31	N/A
9/30/2015	369	-32	N/A	29	N/A
6/30/2015	363	-52	N/A	28	N/A
3/31/2015	359	-56	N/A	23	N/A
12/31/2014	355	-59	N/A	18	N/A
9/30/2014	312	-30	N/A	24	N/A
6/30/2014	268	-1	N/A	31	N/A
3/31/2014	210	12	N/A	44	N/A
12/31/2013	152	24	N/A	58	N/A

アナリストによる今後の成長予測

収入対貯蓄率: MSK今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: MSK今後 3 年間、利益が出ない状態が続くと予測されています。

高成長収益: MSK今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: MSKの収益 ( 15.3% ) German市場 ( 5.5% ) よりも速いペースで成長すると予測されています。

高い収益成長: MSKの収益 ( 15.3% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: MSK 3 年以内に赤字になると予測されています。

MicroPort Scientific 将来の成長

Future 基準チェック /16

主要情報

今後の成長に関する最新情報

Microport Scientific Corporation Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023

No longer forecast to breakeven

MicroPort Scientific Corporation Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2022

MicroPort Scientific Corporation Provides Consolidated Earnings Guidance for the Full Year Ended December 31, 2021

Recent updates

New major risk - Share price stability

First half 2024 earnings released: US$0.053 loss per share (vs US$0.089 loss in 1H 2023)

MicroPort Scientific Corporation to Report First Half, 2024 Results on Aug 30, 2024

MicroPort Scientific Corporation Announces Firesorb Bioresorbable Coronary Scaffold System Obtained Approval for Marketing from the NMPA

Microport Scientific Corporation Announces Retirement of Non-Executive Directors

MicroPort Scientific Corporation, Annual General Meeting, May 22, 2024

Full year 2023 earnings released: US$0.26 loss per share (vs US$0.24 loss in FY 2022)

MicroPort Scientific Corporation to Report Fiscal Year 2023 Results on Mar 28, 2024

New major risk - Share price stability

MicroPort Scientific Corporation Announces Appointment of Peng Bo as Non-Executive Director and Member of the Strategic Committee

First half 2023 earnings released: US$0.089 loss per share (vs US$0.11 loss in 1H 2022)

MicroPort Scientific Corporation to Report First Half, 2023 Results on Aug 30, 2023

Now 22% undervalued after recent price drop

Microport Scientific Corporation Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023

MicroPort Scientific Corporation Announces Board Changes

Independent Non-Executive Director recently sold €247k worth of stock

MicroPort Scientific Corporation, Annual General Meeting, Jun 19, 2023

Independent Non-Executive Director recently sold €612k worth of stock

No longer forecast to breakeven

Full year 2022 earnings released: US$0.24 loss per share (vs US$0.15 loss in FY 2021)

Microport Scientific Corporation Announces That Hiroshi Shirafuji Has Accepted the Invitation to Act as the Honorary Chairman

Less than half of directors are independent

First half 2022 earnings released: US$0.11 loss per share (vs US$0.05 loss in 1H 2021)

MicroPort Scientific Corporation Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2022

Full year 2021 earnings released: US$0.15 loss per share (vs US$0.11 loss in FY 2020)

Less than half of directors are independent

MicroPort Scientific Corporation, Annual General Meeting, Jun 23, 2022

Full year 2021 earnings released: US$0.15 loss per share (vs US$0.11 loss in FY 2020)

MicroPort Scientific Corporation Not to Recommend Final Dividend for the Year Ended 31 December 2021

MicroPort Scientific Corporation Provides Consolidated Earnings Guidance for the Full Year Ended December 31, 2021

First half 2021 earnings released: US$0.05 loss per share (vs US$0.039 loss in 1H 2020)

First half 2021 earnings released: US$0.05 loss per share (vs US$0.039 loss in 1H 2020)

Less than half of directors are independent

Upcoming dividend of HK$0.043 per share

MicroPort Scientific Corporation Proposes Final Dividend for the Year Ended 31 December 2020

Full year 2020 earnings released: US$0.11 loss per share (vs US$0.029 profit in FY 2019)

Full year 2020 earnings released: US$0.11 loss per share (vs US$0.029 profit in FY 2019)

New 90-day high: €5.80

New 90-day high: €4.38

New 90-day high: €3.98

New 90-day low: €3.04

New 90-day low: €3.14

First half earnings released

Earnings released

MicroPort Scientific Corporation to Report First Half, 2020 Results on Aug 27, 2020

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘